{
    "ticker": "PBCRY",
    "name": "Pacific Biosciences of California, Inc.",
    "description": "Pacific Biosciences of California, Inc. (PacBio) is a leading provider of innovative genetic sequencing technologies that enable researchers to better understand the complexities of genomics. Founded in 2004, PacBio has developed a unique platform known as Single Molecule, Real-Time (SMRT) sequencing, which delivers high-quality and long-read sequences that are essential for a wide range of applications, including whole-genome sequencing, targeted resequencing, and transcriptome analysis. The company's flagship product, the Sequel II system, offers unprecedented accuracy and scalability, providing researchers with the tools they need to make significant advancements in areas such as cancer research, reproductive health, and microbiome studies. With a commitment to innovation, PacBio is dedicated to making genomic information more accessible and affordable, thereby accelerating discoveries in life sciences and personalized medicine. The company collaborates with academic institutions, research organizations, and pharmaceutical companies worldwide to drive advancements in genomics and improve healthcare outcomes. PacBio's mission is to enable transformative research and foster a better understanding of biology through the power of advanced sequencing technologies.",
    "industry": [
        "Biotechnology",
        "Genomics"
    ],
    "headquarters": "Menlo Park, California, USA",
    "founded": "2004",
    "website": "https://www.pacb.com",
    "ceo": "Christian Henry",
    "social_media": {
        "twitter": "https://twitter.com/PacBio",
        "linkedin": "https://www.linkedin.com/company/pacific-biosciences/"
    },
    "investor_relations": "https://investor.pacb.com",
    "key_executives": [
        {
            "name": "Christian Henry",
            "position": "CEO"
        },
        {
            "name": "Daniel L. Lichtenstein",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Sequencing Systems",
            "products": [
                "Sequel II System",
                "Sequel IIe System"
            ]
        },
        {
            "category": "Consumables",
            "products": [
                "SMRT Cells",
                "Reagents"
            ]
        }
    ],
    "seo": {
        "meta_title": "Pacific Biosciences | Advanced Genetic Sequencing Solutions",
        "meta_description": "Explore Pacific Biosciences, a leader in genomic sequencing technologies. Learn about PacBio's innovative SMRT sequencing platforms and their impact on life sciences.",
        "keywords": [
            "Pacific Biosciences",
            "Genetic Sequencing",
            "SMRT Sequencing",
            "Genomics",
            "Biotechnology",
            "Personalized Medicine"
        ]
    },
    "faq": [
        {
            "question": "What is Pacific Biosciences known for?",
            "answer": "Pacific Biosciences is known for its advanced genetic sequencing technologies, particularly the SMRT sequencing platform."
        },
        {
            "question": "Who is the CEO of Pacific Biosciences?",
            "answer": "Christian Henry is the CEO of Pacific Biosciences."
        },
        {
            "question": "Where is Pacific Biosciences headquartered?",
            "answer": "Pacific Biosciences is headquartered in Menlo Park, California, USA."
        },
        {
            "question": "What are the main products offered by Pacific Biosciences?",
            "answer": "The main products include the Sequel II and Sequel IIe sequencing systems, as well as SMRT cells and reagents."
        },
        {
            "question": "When was Pacific Biosciences founded?",
            "answer": "Pacific Biosciences was founded in 2004."
        }
    ],
    "competitors": [
        "ILMN",
        "GRMN",
        "BMRN"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "VRTX",
        "REGN"
    ]
}